|
Jun 2026
As of Jun 30, 2026
|
Mar 2026
As of Mar 31, 2026
|
|
|---|---|---|
| Assets | ||
| Assets, Current | ||
| Cash and cash equivalents | ||
| Accounts receivable | ||
| Inventory | ||
| Deferred offering costs | ||
| Other current assets | ||
| Total current assets | ||
| Property and equipment, net | ||
| Right-of-use assets - operating leases | ||
| Other assets | ||
| Total assets | ||
| Liabilities, redeemable convertible preferred stock, and stockholders" equity (deficit) | ||
| Current liabilities | ||
| Accounts payable | ||
| Operating lease liabilities, current | ||
| Product warranty liability | ||
| Accrued payroll, commissions, and bonuses | ||
| Accrued offering costs | ||
| Accrued and other current liabilities | ||
| Total current liabilities | ||
| Warrant liabilities | ||
| Notes payable, net of discount and deferred financing costs | ||
| Convertible notes payable | ||
| Related Party | ||
| Nonrelated Party | ||
| Operating lease liabilities, non-current | ||
| Total liabilities | ||
| Redeemable convertible preferred issuable in series, stock, $0.01 par value, zero and 67,174,403 shares authorized as of June 30, 2026 and December 31, 2025, respectively; zero and 65,591,701 shares issued and outstanding as of June 30, 2026 and December 31, 2025, respectively; aggregate liquidation value of $0 and 182,255 as of June 30, 2026 and December 31, 2025, respectively | ||
| Stockholders' equity (deficit) | ||
| Common stock, $0.01 par value, 950,000,000 and 86,600,000 shares authorized as of June 30, 2026 and December 31, 2025, respectively; 33,286,108 and 884,030 shares outstanding as of June 30, 2026 and December 31, 2025, respectively | ||
| Additional paid-in capital | ||
| Accumulated deficit | ||
| Total stockholders' equity (deficit) | ||
| Total liabilities, redeemable convertible preferred stock, and stockholders' equity (deficit) |
Loading...
